Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea Revises Rules To Curb Rebate Activities, Improve Ethics

Executive Summary

South Korea continues efforts to root out illegal rebate payments for drugs and to step up the pharma industry's ethics and social responsibility by revising relevant rules, but in a way that doesn't harm patients' health.

Advertisement

Related Content

Dong-A Vows Legal Steps As Korea Imposes Heavy Penalties Over Rebates
Dong-A Faces Price Hit As Korea Ups Fight Against Illegal Rebates
Novartis Slapped With New $49m Fine For Korea ‘Rebates’
Price Cuts For Daewoong As Korea Attacks Rebates

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS122718

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel